chr1-196977587-CTG-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_030787.4(CFHR5):c.-76_-75del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000858 in 1,126,836 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 2 hom. )
Consequence
CFHR5
NM_030787.4 5_prime_UTR
NM_030787.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.746
Genes affected
CFHR5 (HGNC:24668): (complement factor H related 5) This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 572 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR5 | NM_030787.4 | c.-76_-75del | 5_prime_UTR_variant | 1/10 | ENST00000256785.5 | ||
CFHR5 | XM_011510020.3 | c.67+2475_67+2476del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR5 | ENST00000256785.5 | c.-76_-75del | 5_prime_UTR_variant | 1/10 | 1 | NM_030787.4 | P1 | ||
CFHR5 | ENST00000699468.1 | c.-116_-115del | 5_prime_UTR_variant | 1/6 | |||||
CFHR5 | ENST00000699466.1 | c.-198+2475_-198+2476del | intron_variant | ||||||
CFHR5 | ENST00000699467.1 | n.127+2001_127+2002del | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00373 AC: 568AN: 152090Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
568
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000894 AC: 224AN: 250536Hom.: 0 AF XY: 0.000613 AC XY: 83AN XY: 135448
GnomAD3 exomes
AF:
AC:
224
AN:
250536
Hom.:
AF XY:
AC XY:
83
AN XY:
135448
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000405 AC: 395AN: 974628Hom.: 2 AF XY: 0.000328 AC XY: 166AN XY: 506856
GnomAD4 exome
AF:
AC:
395
AN:
974628
Hom.:
AF XY:
AC XY:
166
AN XY:
506856
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00376 AC: 572AN: 152208Hom.: 1 Cov.: 32 AF XY: 0.00348 AC XY: 259AN XY: 74426
GnomAD4 genome
AF:
AC:
572
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
259
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mesangiocapillary glomerulonephritis, type II Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at